On Invalid Date, 180 Life Sciences (NASDAQ: ATNF) reported Q4 2023 earnings per share (EPS) of $10.30, up 104.98% year over year. Total 180 Life Sciences earnings for the quarter were -$1.23 million. In the same quarter last year, 180 Life Sciences's earnings per share (EPS) was -$206.87.
As of Q1 2024, 180 Life Sciences's earnings has grown year over year. 180 Life Sciences's earnings in the past year totalled -$19.94 million.
What is ATNF's earnings date?
180 Life Sciences's earnings date is Invalid Date. Add ATNF to your watchlist to be reminded of ATNF's next earnings announcement.
What was ATNF's revenue last quarter?
On Invalid Date, 180 Life Sciences (NASDAQ: ATNF) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, 180 Life Sciences's revenue was $0.00.
What was ATNF's revenue growth in the past year?
As of Q1 2024, 180 Life Sciences's revenue has grown null year over year. 180 Life Sciences's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.